![[Avant + Arrière] Kit de Roulement de roue pour 2013-2015 Honda Crosstour FWD KBB-106677 2021-kia-seltos Numéro de pièce: KBB-105188 KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KBB-106677-01_8439bb8b-f0ff-4049-a38b-ebe2222dec1b.jpg?v=1771443318)
[Avant + Arrière] Kit de Roulement de roue pour 2013-2015 Honda Crosstour FWD KBB-106677 2021-kia-seltos Numéro de pièce: KBB-105188 KDA-100498
EUR205.47EUR235.47
Pay in 4 interest-free payments of $51.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Harbor notes
Description
[Avant + Arrière] Kit de Roulement de roue pour 2013 2015 Honda Crosstour FWD KBB 106677 2021 kia seltos Numéro de pièce: KBB 105188 KDA 100498 Numéro de pièce: KBB 105188 65028 BD8974 4401481 60884 2324 BD60884 ASR 8974 7503 PF7503M SS7503M SS7503X AD7503 QE7503M QE7503X UP7503X D632 632 xCMX D632 7298 H7298 HW7298 H7218 723 NB723 723B Véhicules (consultez le tableau d'ajustement pour des informations détaillées sur le fitment): Produit: Kit de Roulement de roue (Wheel Bearing Kit)
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant + Arrière] Kit de Roulement de roue pour 2013-2015 Honda Crosstour FWD KBB-106677 2021-kia-seltos Numéro de pièce: KBB-105188 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.